Belite Bio Chief Scientific Officer Executes Scheduled Share Sale
Nathan L. Mata, the Chief Scientific Officer at Belite Bio, Inc. (NASDAQ: BLTE), has completed a series of stock transactions totaling $166,283 in American depositary shares. The divestment occurred on April 23, 2026, through multiple trades executed at weighted average prices ranging from $164.47 to $169.56 per share.These sales were carried out u…